{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:32:34Z","timestamp":1793705554153,"version":"4.5.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vaccine.2023.11.015","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:54:59Z","timestamp":1700250899000},"page":"7539-7547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia"],"prefix":"10.1016","volume":"41","author":[{"given":"Ashish C.","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5844-3627","authenticated-orcid":false,"given":"Emma","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8000-6247","authenticated-orcid":false,"given":"Mohana","family":"Rajmokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2709-193X","authenticated-orcid":false,"given":"Stephen B.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.11.015_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2023.11.015_b0010","unstructured":"Lopez A, Harrington T, Marin M. Varicella. Georgia. Centers for Disease Control and Prevention; 2021 [cited 2022 May 06]. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html."},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.015_b0015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmi.2018.11.013","article-title":"Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study","volume":"25","author":"Wu","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2023.11.015_b0020","unstructured":"World Health Organization. Varicella and herpes zoster vaccines: WHO position paper. Geneva. World Health Organization; 2014 June [cited 2022 May 10]. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-wer-8925-265-288."},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.015_b0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jinf.2018.11.009","article-title":"Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program","volume":"78","author":"Quinn","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2023.11.015_b0030","unstructured":"Australian Government Department of Health and Aged Care. Varicella (chickenpox). Canberra: Australian Government Department of Health and Aged Care; 2022 [cited 2022 May 10]. Available from: https:\/\/immunisationhandbook.health.gov.au\/vaccine-preventable-diseases\/varicella-chickenpox."},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.015_b0035","first-page":"268","article-title":"How can we better understand trends in varicella zoster virus-related disease epidemiology?","volume":"194","author":"Heywood","year":"2011","journal-title":"MJA"},{"key":"10.1016\/j.vaccine.2023.11.015_b0040","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.vaccine.2017.05.013","article-title":"Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia","volume":"35","author":"Sheridan","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.015_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125025","article-title":"Increasing trends of herpes zoster in Australia","volume":"10","author":"MacIntyre","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.11.015_b0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.015_b0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S0950268809990860","article-title":"Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia","volume":"138","author":"Gao","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2023.11.015_b0060","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1080\/21645515.2020.1754702","article-title":"Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine","volume":"16","author":"Litt","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.11.015_b0065","unstructured":"Australian Government Department of Health and Aged Care. National Immunisation Program Schedule 1 July 2020. Canberra: Australian Government Department of Health and Aged Care; 2021 [cited 2022 May 10]. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2021\/10\/national-immunisation-program-schedule-for-all-people.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.015_b0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40121-022-00749-y","article-title":"Reduction in herpes zoster antiviral use since the Introduction of the live-attenuated zoster vaccine on Australia\u2019s National Immunisation Program: a population-based study from 1994 to 2019","volume":"12","author":"Phakey","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2023.11.015_b0075","unstructured":"Queensland Health. List of notifiable conditions. Brisbane: Queensland Health; 2020 [cited 2022 Mar 31]. Available from: https:\/\/www.health.qld.gov.au\/clinical-practice\/guidelines-procedures\/diseases-infection\/notifiable-conditions\/list#types."},{"key":"10.1016\/j.vaccine.2023.11.015_b0080","unstructured":"Queensland Health. Vaccine preventable and invasive diseases in Queensland. Brisbane: Queensland Health; 2022 [cited 2022 May 10]. Available from: https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0024\/1142826\/VPD-report-2021.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0085","unstructured":"The Federal Relations Secretariat Commonwealth-State Relations Division. Project agreement for vaccine preventable diseases surveillance program. Canberra: The Federal Relations Secretariat Commonwealth-State Relations Division; 2020 [cited 2022 September 27]. Available from: https:\/\/federalfinancialrelations.gov.au\/sites\/federalfinancialrelations.gov.au\/files\/2020-08\/vaccines_preventable_diseases_surveillance_program.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0090","unstructured":"The Federal Relations Secretariat Commonwealth-State Relations Division. Project agreement for vaccine preventable diseases surveillance program. Canberra: The Federal Relations Secretariat Commonwealth-State Relations Division; 2014 [cited 2022 September 27]. Available from: https:\/\/federalfinancialrelations.gov.au\/sites\/federalfinancialrelations.gov.au\/files\/2021-07\/Vaccine_Preve_Disease_Surv_Prog_endingJun17-PA.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0095","unstructured":"Queensland Government. Public Health Regulation 2018. Brisbane: Queensland Health; 2022 [cited 2022 November 11]. Available from: https:\/\/www.legislation.qld.gov.au\/view\/pdf\/inforce\/current\/sl-2018-0117."},{"key":"10.1016\/j.vaccine.2023.11.015_b0100","unstructured":"Queensland Health. Varicella-zoster infection (chickenpox and shingles). Brisbane: Queensland Health; 2020 [cited 2022 Mar 31]. Available from: https:\/\/www.health.qld.gov.au\/cdcg\/index\/varicella."},{"key":"10.1016\/j.vaccine.2023.11.015_b0105","unstructured":"Australian Bureau of Statistics. National, state and territory population. Canberra: Australian Bureau of Statistics; 2022 [cited 2022 Oct 10]. Available from: https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/latest-release#data-download."},{"key":"10.1016\/j.vaccine.2023.11.015_b0110","first-page":"42","article-title":"Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998\u20132015","volume":"2018","author":"Sheel","year":"2018","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2023.11.015_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12877-017-0420-9","article-title":"The temporal impact of aging on the burden of herpes zoster","volume":"17","author":"Varghese","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.vaccine.2023.11.015_b0120","unstructured":"Australian Government Department of Health and Aged Care. Australia\u2019s notifiable disease status, 2015: Annual report of the National Notifiable Diseases Surveillance System. Canberra: Australian Government Department of Health and Aged Care; 2019 [cited 2022 May 10]. Available from: https:\/\/www.health.gov.au\/resources\/publications\/australias-notifiable-disease-status-2015-annual-report-of-the-national-notifiable-diseases-surveillance-system?language=en."},{"key":"10.1016\/j.vaccine.2023.11.015_b0125","unstructured":"Australian Government Department of Health and Aged Care. Australia\u2019s notifiable disease status, 2016: Annual report of the National Notifi able Diseases Surveillance System. Canberra: Australian Government Department of Health and Aged Care; 2021 [cited 2022 May 10]. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2021\/09\/australia-s-notifiable-disease-status-2016-annual-report-of-the-national-notifiable-diseases-surveillance-system-australia-s-notifiable-disease-status-2016-annual-report-of-the-national-interoperable-notifiable-diseases-su.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0130","unstructured":"Australian Government Department of Health and Aged Care. Australia\u2019s notifiable disease status, 2014: Annual report of the National Notifiable Diseases Surveillance System. Canberra: Australian Government Department of Health and Aged Care; 2016 [cited 2022 May 10]. Available from: https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-cdi4001-pdf-cnt.htm\/$FILE\/cdi4001e.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0135","unstructured":"National Centre for Immunisation Research and Surveillance. Annual immunisation coverage report 2021. NSW: National Centre for Immunisation Research and Surveillance; 2022 [cited 2022 Dec 24]. Available from: https:\/\/ncirs.org.au\/sites\/default\/files\/2022-12\/NCIRS%20Annual%20Immunisation%20Coverage%20Report%202021_FINAL.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0140","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.11.015_b0145","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain","volume":"9","author":"Cenoz","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.11.015_b0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.015_b0155","unstructured":"Centers for Disease Control and Prevention. Varicella Vaccine Recommendations. Atlanta: Centers for Disease Control and Prevention 2021 [cited 2022 Dec 6]. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/varicella\/hcp\/recommendations.html."},{"key":"10.1016\/j.vaccine.2023.11.015_b0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.11.015_b0165","unstructured":"National Centre for Immunisation Research and Surveillance. Zoster vaccines for Australian adults. NSW: National Centre for Immunisation Research and Surveillance; 2021 [cited 2022 Nov 24]. Available from: https:\/\/www.ncirs.org.au\/sites\/default\/files\/2021-07\/Zoster\u00a0%20vaccine\u00a0%20for\u00a0%20Australian\u00a0%20adults\u00a0%20fact\u00a0%20sheet_19\u00a0%20July\u00a0%202021_Final.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0170","unstructured":"National Centre for Immunisation Research and Surveillance. Herpes zoster. NSW: National Centre for Immunisation Research and Surveillance; 2017 [cited 2022 Nov 24]. Available from: https:\/\/www.ncirs.org.au\/sites\/default\/files\/2018-12\/zoster-vaccine-fact-sheet.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0175","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 Years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.015_b0180","unstructured":"Australian Government Department of Health and Aged Care. Statement on the clinical use of zoster vaccines in older adults in Australia. Canberra: Australian Government Department of Health and Aged Care; 2021 [cited 2022 November 11]. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2021\/07\/statement-on-the-clinical-use-of-zoster-vaccine-in-older-adults-in-australia-statement-on-the-clinical-use-of-zoster-vaccine-in-older-adults-in-australia.pdf."},{"key":"10.1016\/j.vaccine.2023.11.015_b0185","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.015_b0190","unstructured":"Australian Government Department of Health and Aged Care. zoster (herpes zoster). Canberra: Australian Government Department of Health and Aged Care; 2022 [cited 2022 May 10]. Available from: https:\/\/immunisationhandbook.health.gov.au\/vaccine-preventable-diseases\/zoster-herpes-zoster."},{"key":"10.1016\/j.vaccine.2023.11.015_b0195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.11.015_b0200","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/cid\/ciab629","article-title":"The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: Interim results of an extension study of the pivotal phase 3 clinical trials ZOE-50 and ZOE-70","volume":"74","author":"Boutry","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.015_b0205","unstructured":"Australian Government Department of Health and Aged Care. Changes to the recommended use of zoster vaccines. Canberra: Australian Government Department of Health and Aged Care; 2022 [cited 2022 Oct 10]. Available from: https:\/\/consultations.health.gov.au\/ohp-immunisation-branch\/proposed-changes-to-recommended-use-zoster-vaccine\/supporting_documents\/AIHZOSTERPC071Jul22.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:03Z","timestamp":1759404723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23013270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":41,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0264410X23013270"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}